Sign In
Buy IHE
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
4 Hot Pharmaceutical ETFs
03:00pm, Sunday, 14'th Jul 2019
Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. With Johnson and Johnson
AbbVie to Buy Allergan: Prescribed ETFs
03:00pm, Wednesday, 26'th Jun 2019
AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.
AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs
10:01pm, Tuesday, 25'th Jun 2019
Pharmaceutical sector-specific exchange traded funds showed mixed results Tuesday after AbbVie (NYSE: ABBV) agreed to acquire Allergan (NYSE: AGN) for $63 billion. Among the largest pharma-specific ET
Pharma ETFs Down Despite Solid Q1 Results
02:05pm, Thursday, 09'th May 2019
Despite such robust results, pharma ETFs have been trending downward in a month.
Pharmaceutical ETFs Catch Healthcare Contagion
09:00pm, Thursday, 18'th Apr 2019
The retreat in healthcare stocks is bleeding over, with areas like pharmaceutical sector exchange traded funds being dragged down by association. The iShares U.S. Pharmaceuticals ETF (IHE) continue
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus
02:35pm, Wednesday, 17'th Apr 2019
Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast
4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat
06:14pm, Tuesday, 09'th Apr 2019
Big pharmaceutical companies were on the hot seat at Capitol Hill today with CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare's OptumRx testifying before the Senate Finance Committ
